BVT announced today that it has submitted registration documents in Switzerland for its proprietary active ingredient, Clonostachys rosea CR-7 for use against fungal diseases in production agriculture. Switzerland uses approximately CDN$40 million/year in chemical fungicides where growers are increasingly seeking non-chemical alternatives and represents the company’s beachhead into Europe. The entire European fungicide and insecticide market is approximately CDN $9.0 billion, of which approximately CDN$1.0 billion is a target for BVT’s bee delivery system.
BVT today provided a corporate update and review of current business initiatives. Development of BVT’s vectoring delivery system, utilizing VECTORITETM with CR-7, is largely complete so the primary objective is now full commercial launch in the US. Second to this is the selective expansion into markets outside the US, across crop varieties, and through strategic or synergistic product development.
BVT is pleased to announce the closing of its non-brokered private placement of 500,000 units of the Company at a price of $0.25 per unit for gross proceeds of C$125,000 (the “Offering”). Each unit consists of one common share and one common share purchase warrant (“Unit”). Each common share purchase warrant (“Warrant”) entitles the holder to purchase one additional common share at a price of C$0.35 per common share until May 2, 2020.
BVT is pleased to provide an update on its work in the Florida strawberry market this past winter. Five notable, Florida-based strawberry growers used BVT’s proprietary crop production system starting in late December 2017 through March 2018 across 13 fields and covering a total of over 170 acres.
BVT is pleased to announce the appointment of Brandon Boddy to the board of directors of BVT. Brandon contributes 14 years of capital markets experience and directly as a principal. Mr. Boddy is a founding director of both Cannabis Wheaton Income Corp. and Global Blockchain Technologies Corp. From 2006 to 2014, Brandon acted in the capacity of Vice President at Canaccord Financial Inc., as well as Principal and Senior Vice President at Jordan Capital Markets.
BVT is pleased to announce that it has received two new key patent application allowances.
BVT is pleased to announce the closing of its non-brokered private placement of 12,000,000 units of the Company at a price of $0.25 per unit for gross proceeds of C$3,000,000 (the “Offering”). Each unit consists of one common share and one common share purchase warrant (“Unit”). Each common share purchase warrant (“Warrant”) entitles the holder to purchase one additional common share at a price of C$0.35 per common share until March 28, 2020.
BVT announces the appointment, on a contractual basis, of Dr. Gerardo Suazo, Ph.D., M.B.A. to the position of Senior Technical Manager. Mexico is a market where about $250M of chemical fungicides are being used today, and where growers are already actively modifying their production practices to meet standards demanding higher levels of food safety and quality with less chemical inputs.
BVT is pleased to announce the closing of its non-brokered private placement for gross proceeds of C$1,575,000 (the “Offering”). The Offering was oversubscribed and the Company issued an additional 1,500,000 units as to what was previously announced for a total of 6,300,000 units of the Company at a price of $0.25 per unit.
BVT is pleased to announce successful results from trials in sunflowers conducted during 2017. The trials were designed to evaluate the ability of the BVT system consisting of a bee hive with dispenser technology through which BVT’s proprietary plant beneficial microbe is delivered to crops, to manage sclerotinia head rot, an invasive fungal disease that causes high levels of loss in sunflowers and currently has no viable method of prevention.
Connect with us
Have a question about BVT, the bee vectoring process, sustainable farming practices or just want to share feedback? We want to hear from you!